Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This additional mechanism accounts for the 56 percentage point efficacy advantage
aligns with phase 2 obesity trial readouts
This structure protects patient safety while allowing pharmacists to prepare individualized dosing strengths and formulations that may not be commercially available in standardized form
Claims submitted without the AT modifier deny regardless of documentation
US$ 27.67
US$ 28.49
US$ 25.71
US$ 20.02
US$ 23.92
US$ 27.51
US$ 22.51
US$ 26.86
US$ 24.78
